| scholarly article | Q13442814 |
| P2093 | author name string | Bernstein L | |
| Frösing R | |||
| Hayes AA | |||
| Spears CP | |||
| Gustavsson BG | |||
| Berne M | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5894-5900 | |
| P577 | publication date | 1988-10-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil | |
| P478 | volume | 48 |
| Q37270356 | 5-Fluorouracil: mechanisms of resistance and reversal strategies |
| Q36691968 | Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status |
| Q67541455 | Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells |
| Q34567805 | Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine |
| Q72368976 | Changes in folate concentration in Yoshida sarcoma after administration of leucovorin or cisplatin |
| Q38631279 | Clinical pharmacology of 5-fluorouracil |
| Q45113388 | Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer |
| Q72400006 | Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells |
| Q31935218 | Determinants of prognosis and response to therapy in colorectal cancer |
| Q42108821 | Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases |
| Q36142392 | Effect of leucovorin on the antitumor efficacy of the 5-FU prodrug, tegafur-uracil, in human colorectal cancer xenografts with various expression levels of thymidylate synthase |
| Q39180988 | Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase |
| Q40275457 | Exploring the intracellular pharmacokinetics of the 5-fluorouracil nucleotides during capecitabine treatment. |
| Q36148634 | Folic Acid-Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2'-Deoxyuridine in Colorectal Cancer Cell Lines |
| Q41238678 | Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration |
| Q71612879 | Histopathological response to preoperative chemotherapy including 5-fluorouracil additionally assessed by immunocytochemical and pharmacologic parameters in patients with advanced gastric cancer |
| Q41148056 | How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer |
| Q42389744 | In vitro antitumour activity of cis- and trans-5-fluoro-5,6-dihydro-6-alkoxy-uracils; effects on thymidylate synthesis |
| Q55334229 | In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin |
| Q39837916 | Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase |
| Q72575174 | Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts |
| Q70733006 | Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo |
| Q40390814 | New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: Thymidylate synthase |
| Q41234796 | Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells |
| Q71971495 | The effect of different routes of administration of 5-fluorouracil on thymidylate synthase inhibition in the rat |
| Q40423844 | Thymidylate synthase and drug resistance |
| Q38997864 | Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects. |
Search more.